nodes	percent_of_prediction	percent_of_DWPC	metapath
Drostanolone—SHBG—blood plasma—schizophrenia	0.0605	0.142	CbGeAlD
Drostanolone—CYP19A1—forebrain—schizophrenia	0.0269	0.0632	CbGeAlD
Drostanolone—SHBG—gonad—schizophrenia	0.0254	0.0598	CbGeAlD
Drostanolone—AR—forebrain—schizophrenia	0.0238	0.056	CbGeAlD
Drostanolone—SHBG—blood—schizophrenia	0.0222	0.0521	CbGeAlD
Drostanolone—AR—telencephalon—schizophrenia	0.0219	0.0515	CbGeAlD
Drostanolone—AR—Nuclear Receptors—NR4A2—schizophrenia	0.0211	0.0422	CbGpPWpGaD
Drostanolone—CYP19A1—gonad—schizophrenia	0.0206	0.0485	CbGeAlD
Drostanolone—Testosterone Propionate—COMT—schizophrenia	0.0194	0.261	CrCbGaD
Drostanolone—SHBG—endocrine gland—schizophrenia	0.0192	0.0452	CbGeAlD
Drostanolone—Trilostane—ESR1—schizophrenia	0.0192	0.257	CrCbGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—PAWR—schizophrenia	0.0191	0.0381	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NOS1AP—schizophrenia	0.0184	0.0368	CbGpPWpGaD
Drostanolone—AR—gonad—schizophrenia	0.0182	0.0429	CbGeAlD
Drostanolone—SHBG—Nongenotropic Androgen signaling—FOS—schizophrenia	0.0181	0.0361	CbGpPWpGaD
Drostanolone—CYP19A1—blood—schizophrenia	0.018	0.0423	CbGeAlD
Drostanolone—SHBG—central nervous system—schizophrenia	0.0173	0.0408	CbGeAlD
Drostanolone—SHBG—cerebellum—schizophrenia	0.0169	0.0398	CbGeAlD
Drostanolone—AR—Nuclear Receptor transcription pathway—NR4A2—schizophrenia	0.0167	0.0333	CbGpPWpGaD
Drostanolone—AR—blood—schizophrenia	0.0159	0.0374	CbGeAlD
Drostanolone—CYP19A1—endocrine gland—schizophrenia	0.0156	0.0367	CbGeAlD
Drostanolone—CYP19A1—nervous system—schizophrenia	0.0146	0.0343	CbGeAlD
Drostanolone—CYP19A1—central nervous system—schizophrenia	0.014	0.033	CbGeAlD
Drostanolone—AR—endocrine gland—schizophrenia	0.0138	0.0325	CbGeAlD
Drostanolone—AR—Regulation of Androgen receptor activity—SMARCA2—schizophrenia	0.0138	0.0275	CbGpPWpGaD
Drostanolone—SHBG—brain—schizophrenia	0.0137	0.0324	CbGeAlD
Drostanolone—AR—nervous system—schizophrenia	0.0129	0.0304	CbGeAlD
Drostanolone—AR—central nervous system—schizophrenia	0.0124	0.0293	CbGeAlD
Drostanolone—CYP19A1—Tryptophan metabolism—TPH1—schizophrenia	0.0118	0.0236	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—TLE1—schizophrenia	0.0117	0.0235	CbGpPWpGaD
Drostanolone—CYP19A1—brain—schizophrenia	0.0111	0.0262	CbGeAlD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP26B1—schizophrenia	0.0107	0.0214	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP26B1—schizophrenia	0.0106	0.0211	CbGpPWpGaD
Drostanolone—AR—brain—schizophrenia	0.00986	0.0232	CbGeAlD
Drostanolone—AR—Androgen receptor signaling pathway—PAK6—schizophrenia	0.00952	0.019	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—TCF4—schizophrenia	0.00876	0.0175	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP26B1—schizophrenia	0.00869	0.0174	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—BDNF—schizophrenia	0.00796	0.0159	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TLE1—schizophrenia	0.00767	0.0153	CbGpPWpGaD
Drostanolone—SHBG—Nongenotropic Androgen signaling—AKT1—schizophrenia	0.00724	0.0145	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TCF4—schizophrenia	0.00705	0.0141	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR3A—schizophrenia	0.00682	0.0136	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—NDST3—schizophrenia	0.00664	0.0133	CbGpPWpGaD
Drostanolone—CYP19A1—Tryptophan metabolism—CYP1A2—schizophrenia	0.00647	0.0129	CbGpPWpGaD
Drostanolone—Testosterone—MAOA—schizophrenia	0.00636	0.0853	CrCbGaD
Drostanolone—Estradiol—ESR1—schizophrenia	0.00603	0.0809	CrCbGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP2D6—schizophrenia	0.00579	0.0116	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP2D6—schizophrenia	0.00571	0.0114	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—FOS—schizophrenia	0.0056	0.0112	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptors—ESR1—schizophrenia	0.00528	0.0105	CbGpPWpGaD
Drostanolone—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP1A2—schizophrenia	0.00523	0.0105	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—HSPA8—schizophrenia	0.00522	0.0104	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TPH1—schizophrenia	0.00517	0.0103	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA7—schizophrenia	0.00517	0.0103	CbGpPWpGaD
Drostanolone—CYP19A1—Oxidation by Cytochrome P450—CYP1A2—schizophrenia	0.00517	0.0103	CbGpPWpGaD
Drostanolone—Progesterone—ESR1—schizophrenia	0.00512	0.0687	CrCbGaD
Drostanolone—AR—FOXA1 transcription factor network—ESR1—schizophrenia	0.00469	0.00937	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP2D6—schizophrenia	0.00469	0.00937	CbGpPWpGaD
Drostanolone—Estradiol—CYP1A2—schizophrenia	0.00465	0.0624	CrCbGaD
Drostanolone—CYP19A1—Biological oxidations—CYP26B1—schizophrenia	0.00462	0.00922	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP26B1—schizophrenia	0.00455	0.00909	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GRIN1—schizophrenia	0.0043	0.00859	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—CYP1A2—schizophrenia	0.00424	0.00847	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—FOS—schizophrenia	0.00423	0.00845	CbGpPWpGaD
Drostanolone—AR—Nuclear Receptor transcription pathway—ESR1—schizophrenia	0.00417	0.00833	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GCLM—schizophrenia	0.00411	0.00822	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—GAPDH—schizophrenia	0.00406	0.0081	CbGpPWpGaD
Drostanolone—Progesterone—CYP1A2—schizophrenia	0.00395	0.053	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TPH2—schizophrenia	0.00392	0.00782	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNB2—schizophrenia	0.00371	0.00741	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—GSK3B—schizophrenia	0.00367	0.00733	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—IL10—schizophrenia	0.00367	0.00732	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—MEF2C—schizophrenia	0.00357	0.00712	CbGpPWpGaD
Drostanolone—CYP19A1—Phase 1 - Functionalization of compounds—MAOA—schizophrenia	0.00353	0.00705	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—YWHAZ—schizophrenia	0.00348	0.00695	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—CHRNA4—schizophrenia	0.00337	0.00673	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR1A—schizophrenia	0.00324	0.00648	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SNAP25—schizophrenia	0.00313	0.00625	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—SLC6A4—schizophrenia	0.00313	0.00625	CbGpPWpGaD
Drostanolone—Progesterone—CYP2D6—schizophrenia	0.00305	0.0409	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—NTRK2—schizophrenia	0.00305	0.00608	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NR4A2—schizophrenia	0.00288	0.00576	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—ESR1—schizophrenia	0.00288	0.00575	CbGpPWpGaD
Drostanolone—AR—FOXA1 transcription factor network—EP300—schizophrenia	0.0028	0.0056	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TH—schizophrenia	0.00279	0.00558	CbGpPWpGaD
Drostanolone—AR—Notch-mediated HES/HEY network—EP300—schizophrenia	0.00266	0.00531	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—FOS—schizophrenia	0.0026	0.00519	CbGpPWpGaD
Drostanolone—Estradiol—ABCB1—schizophrenia	0.00256	0.0344	CrCbGaD
Drostanolone—CYP19A1—Biological oxidations—CYP2D6—schizophrenia	0.00249	0.00498	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP2D6—schizophrenia	0.00246	0.00491	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—ACSL6—schizophrenia	0.00245	0.0049	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—SLC27A5—schizophrenia	0.00245	0.0049	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—GSK3B—schizophrenia	0.00242	0.00484	CbGpPWpGaD
Drostanolone—AR—Gene Expression—TSNAX—schizophrenia	0.00242	0.00482	CbGpPWpGaD
Drostanolone—AR—Regulation of Androgen receptor activity—EP300—schizophrenia	0.00241	0.00482	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MAOA—schizophrenia	0.00236	0.00471	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—BDNF—schizophrenia	0.00227	0.00454	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—CYP1A2—schizophrenia	0.00225	0.0045	CbGpPWpGaD
Drostanolone—AR—Nongenotropic Androgen signaling—AKT1—schizophrenia	0.00224	0.00447	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—CYP1A2—schizophrenia	0.00222	0.00444	CbGpPWpGaD
Drostanolone—Progesterone—ABCB1—schizophrenia	0.00218	0.0292	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL10—schizophrenia	0.00217	0.00434	CbGpPWpGaD
Drostanolone—CYP19A1—FSH signaling pathway—AKT1—schizophrenia	0.00215	0.0043	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—MEF2C—schizophrenia	0.00211	0.00422	CbGpPWpGaD
Drostanolone—Testosterone—ABCB1—schizophrenia	0.00206	0.0276	CrCbGaD
Drostanolone—AR—SIDS Susceptibility Pathways—YWHAZ—schizophrenia	0.00204	0.00408	CbGpPWpGaD
Drostanolone—AR—Gene Expression—LSM1—schizophrenia	0.00197	0.00393	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIP4K2A—schizophrenia	0.00196	0.00391	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—BDNF—schizophrenia	0.00193	0.00386	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—HTR2A—schizophrenia	0.00192	0.00384	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ABCB1—schizophrenia	0.0019	0.0038	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—COMT—schizophrenia	0.00189	0.00377	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTP1—schizophrenia	0.00188	0.00375	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—MAOA—schizophrenia	0.00188	0.00375	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—COMT—schizophrenia	0.00186	0.00372	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTP1—schizophrenia	0.00185	0.0037	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—PLA2G4A—schizophrenia	0.00185	0.00369	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.00175	0.0035	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—schizophrenia	0.00174	0.00347	CbGpPWpGaD
Drostanolone—CYP19A1—Biological oxidations—GSTM1—schizophrenia	0.00173	0.00345	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—EP300—schizophrenia	0.00172	0.00343	CbGpPWpGaD
Drostanolone—CYP19A1—Metapathway biotransformation—GSTM1—schizophrenia	0.0017	0.0034	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PRODH—schizophrenia	0.00162	0.00323	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—EP300—schizophrenia	0.00159	0.00318	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—ESR1—schizophrenia	0.00151	0.00301	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PRKD1—schizophrenia	0.00149	0.00297	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—NOTCH4—schizophrenia	0.00148	0.00295	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—ESR1—schizophrenia	0.00145	0.0029	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NR4A2—schizophrenia	0.00139	0.00277	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MPC2—schizophrenia	0.00132	0.00263	CbGpPWpGaD
Drostanolone—AR—Coregulation of Androgen receptor activity—AKT1—schizophrenia	0.0013	0.0026	CbGpPWpGaD
Drostanolone—AR—Gene Expression—SMG6—schizophrenia	0.00127	0.00253	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CLOCK—schizophrenia	0.00123	0.00245	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLCH2—schizophrenia	0.00122	0.00245	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NDST3—schizophrenia	0.00115	0.0023	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—IL1B—schizophrenia	0.00114	0.00227	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SLC27A5—schizophrenia	0.00109	0.00218	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ACSL6—schizophrenia	0.00109	0.00218	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	0.00107	0.00213	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.00104	0.00209	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—DAO—schizophrenia	0.00104	0.00208	CbGpPWpGaD
Drostanolone—AR—Regulation of nuclear SMAD2/3 signaling—AKT1—schizophrenia	0.00104	0.00208	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—EP300—schizophrenia	0.00102	0.00203	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PNP—schizophrenia	0.000998	0.00199	CbGpPWpGaD
Drostanolone—AR—Androgen receptor signaling pathway—AKT1—schizophrenia	0.000964	0.00192	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—NDUFV2—schizophrenia	0.000928	0.00185	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—EP300—schizophrenia	0.000899	0.0018	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIP4K2A—schizophrenia	0.000873	0.00174	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	0.000866	0.00173	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	0.000865	0.00173	CbGpPWpGaD
Drostanolone—AR—SIDS Susceptibility Pathways—TNF—schizophrenia	0.000826	0.00165	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP26B1—schizophrenia	0.000789	0.00158	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.000748	0.00149	CbGpPWpGaD
Drostanolone—AR—Generic Transcription Pathway—ESR1—schizophrenia	0.00072	0.00144	CbGpPWpGaD
Drostanolone—AR—Gene Expression—NOTCH4—schizophrenia	0.00071	0.00142	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TPH1—schizophrenia	0.000703	0.00141	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GCLM—schizophrenia	0.000703	0.00141	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	0.000703	0.0014	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	0.000663	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PRKD1—schizophrenia	0.000661	0.00132	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—TP53—schizophrenia	0.000643	0.00128	CbGpPWpGaD
Drostanolone—AR—Gene Expression—DNMT1—schizophrenia	0.000637	0.00127	CbGpPWpGaD
Drostanolone—AR—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000631	0.00126	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HSPA8—schizophrenia	0.000628	0.00125	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	0.000619	0.00124	CbGpPWpGaD
Drostanolone—AR—Gene Expression—HSPA1A—schizophrenia	0.000572	0.00114	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GAPDH—schizophrenia	0.000552	0.0011	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CLOCK—schizophrenia	0.000547	0.00109	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	0.000546	0.00109	CbGpPWpGaD
Drostanolone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—schizophrenia	0.000543	0.00108	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	0.00054	0.00108	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TPH2—schizophrenia	0.000533	0.00106	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CACNB2—schizophrenia	0.000533	0.00106	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—DPYD—schizophrenia	0.000524	0.00105	CbGpPWpGaD
Drostanolone—AR—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	0.000523	0.00104	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CACNA1C—schizophrenia	0.000488	0.000974	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PIK3C2A—schizophrenia	0.000475	0.000949	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP2D6—schizophrenia	0.000426	0.000851	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—SNAP25—schizophrenia	0.000426	0.000851	CbGpPWpGaD
Drostanolone—AR—Gene Expression—YWHAZ—schizophrenia	0.000415	0.000829	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—CYP1A2—schizophrenia	0.000385	0.00077	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—TH—schizophrenia	0.00038	0.000759	CbGpPWpGaD
Drostanolone—AR—Gene Expression—ESR1—schizophrenia	0.000347	0.000693	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—COMT—schizophrenia	0.000323	0.000645	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTP1—schizophrenia	0.000321	0.000642	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MAOA—schizophrenia	0.000321	0.000641	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	0.000311	0.000621	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—ABCB1—schizophrenia	0.000304	0.000608	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—GSTM1—schizophrenia	0.000295	0.00059	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—PLA2G4A—schizophrenia	0.000295	0.00059	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—MTHFR—schizophrenia	0.000261	0.000521	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOE—schizophrenia	0.000243	0.000485	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—APOA1—schizophrenia	0.00024	0.00048	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—EP300—schizophrenia	0.000139	0.000277	CbGpPWpGaD
Drostanolone—AR—Gene Expression—AKT1—schizophrenia	0.000125	0.00025	CbGpPWpGaD
Drostanolone—CYP19A1—Metabolism—AKT1—schizophrenia	8.37e-05	0.000167	CbGpPWpGaD
